ClinicalTrials.gg
Not yet recruitingNCT07705763Updated Jul 15, 2026

Comparison of Ketorolac Tromethamine 0.5%-Soaked Bandage Contact Lenses Versus Non-Medicated Bandage Contact Lenses on Postoperative Pain Control After Photorefractive Keratectomy

An interventional study of Ketorolac Tromethamine 0.5%-Soaked Bandage Contact Lenses and Contact Bandage Lenses in Refraction Error and Photorefractive Keratectomy, sponsored by Madina Teaching Hospital Faisalabad. Not yet recruiting at 1 site in Pakistan. Open to participants aged 21 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-15.

Sponsored by Madina Teaching Hospital Faisalabad · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 40 Years
Sex
All
01

Study summary

Photorefractive keratectomy (PRK) is a well-established surface ablation procedure for the correction of refractive errors. Despite excellent visual and refractive outcomes, postoperative pain remains a significant concern, particularly during the first few days following surgery. This pain is primarily related to corneal epithelial removal, exposure of subepithelial nerve endings, and the subsequent inflammatory response. Effective pain management is therefore essential to enhance patient comfort, improve compliance with postoperative care, and increase overall surgical satisfaction. Therefore we will compare postoperative pain levels in patients undergoing PRK using ketorolac tromethamine 0.5%-soaked bandage contact lenses versus non-medicated bandage contact lenses.

02

Conditions studied

  • Refraction Error
  • Photorefractive Keratectomy

Browse trials for

Keywords

  • Ketorolac tromethamine
  • Non-Medicated Bandage Contact Lenses
  • Postoperative Pain Control
03

In context

Refractive Errors

420 studies on the registry are indexed under Refractive Errors; 59 are open to participants now.

This study's planned enrollment of 60 is below the median of 76 across 301 interventional studies indexed under Refractive Errors.

Browse Refractive Errors studies →

Lead sponsor

This is the only study on the registry with Madina Teaching Hospital Faisalabad as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants selected to undergo photorefractive keratectomy for correction of refractive error after complete workup.
  • Participants willing to participate in the study after detailed explanation of the research purpose.

Exclusion criteria

Exclusion Criteria:

  • Known to NSAIDs or ketorolac.
  • Presence of any systemic diseases affecting wound healing.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group A Participants who will receive Ketorolac Tromethamine 0.5%-Soaked Bandage Contact Lenses

    Group A will receive ketorolac-soaked bandage contact lenses immediately after surgery. Postoperative pain will be assessed using Visual Analogue Scale at defined intervals. Epithelial healing will be monitored clinically until complete re-epithelialization. Any complications arising during postoperative period will be documented for each group.

    Device: Ketorolac Tromethamine 0.5%-Soaked Bandage Contact Lenses

  • Active comparator
    Group B Participants who will receive Non-Medicated Bandage Contact Lenses

    Group B will receive standard non-medicated bandage contact lenses. Postoperative pain will be assessed using Visual Analogue Scale at defined intervals. Epithelial healing will be monitored clinically until complete re-epithelialization. Any complications arising during postoperative period will be documented for each group.

    Device: Contact Bandage Lenses

Interventions

  • DeviceKetorolac Tromethamine 0.5%-Soaked Bandage Contact Lenses

    Soaking Bandage Contact Lenses in ketorolac prior to application may provide sustained drug release at the ocular surface, thereby enhancing postoperative pain control while reducing the need for repeated topical administration.Recent studies have suggested that ketorolac-soaked Bandage Contact Lenses may significantly reduce pain following Photorefractive Keratectomy without adversely affecting epithelial healing

  • DeviceContact Bandage Lenses

    Bandage contact lenses (BCLs) are routinely used after PRK to protect the corneal surface, reduce mechanical irritation from blinking, and promote epithelial healing

06

What researchers measure

Primary outcomes

  1. Postoperative Pain

    Postoperative pain assessed using a standardized pain scoring system (e.g., Visual Analogue Scale) at 6, 24, 48, and 72 hours postoperatively.

    Time frame: 72 hours

Secondary outcomes

  1. Epithelial Healing

    Time for epithelial healing

    Time frame: 72 hours

07

Study locations

1 site
  • Madina Teaching Hospital Faisalabad
    Faisalābad, Punjab Province 38000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07705763
Lead sponsor
Madina Teaching Hospital Faisalabad
Responsible party
Hassan Abbas (Principal Investigator, Madina Teaching Hospital Faisalabad) — Principal investigator
First posted
Jul 15, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Jul 15, 2026

Study contacts

Dr Hassan Abbas, MBBS
Contact
abbas.hassan97@gmail.com
+923076781178

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion